XtalPi
An AI and robotics-driven pharmaceutical R&D platform enterprise, officially stated that it takes Agentic AI as the intelligent hub, uses more than 200 vertical-domain AI models for predictive design, and has laboratory robots complete wet experiments, forming a self-iterative R&D closed loop of dry and wet experiments.
Updated: 2026-10-26
What is XtalPi?
Insilico Medicine officially positions itself as empowering industrial innovation with an artificial intelligence and robotics technology platform. Its mission is to accelerate the discovery of new molecules and the creation of new materials through Agentic AI for understanding and decision-making, as well as physical intelligent experimentation and verification. It splits R&D into three layers: Genius Agents serve as the intelligent hub to orchestrate tasks; over 200 vertical-domain AI models complete prediction and design; and laboratory embodied intelligent robots are responsible for 7×24-hour wet experiment execution and data collection.
Who is it for?
- Early R&D teams of innovative pharmaceutical companies: Compress the optimization cycle of lead compounds through computational prediction and automated experiments.
- Formulation teams that need to solve polymorphism and solid-state problems: Leverage crystallization prediction and automated experimental platforms.
- New material and new energy enterprises: Apply automated experimental capabilities to formula screening for systems such as electrolytes.
- Universities and research institutions: Evaluate the applicability of laboratory automation solutions to their own research projects.
- R&D managers: Compare the input-output ratios of two approaches: building in-house experimental automation and cooperating with external parties.
Key features
6Genius Agents Intelligent Hub
The company states that it understands research intentions, orchestrates vertical domain models and laboratory robots, and drives the independent iteration of wet and dry experiments.
Material Discovery Domain Models
The company states that it has trained over 200 vertical-domain AI models based on collected compound and reaction data, which are used for experimental design, prediction, and analysis.
Lab Embodied Intelligent Robots
The company states that it independently develops robots capable of performing wet experiment execution and data collection 24/7, and can provide customized solutions.
Software and Agent Applications
The company provides software platforms such as drug patent mining, free energy perturbation affinity prediction, and multi-functional molecular design.
Drug Discovery Services
The company states that it offers capabilities for small-molecule drug discovery and antibody drug discovery, covering the entire process from target identification to preclinical candidate drugs.
Solid State Form and Future Chemistry
The company provides a drug solid state form R&D platform, one-stop chemical services, and automated chemical synthesis capabilities.
How to use XtalPi
- First clarify the specific R&D problems to be solved, then select the corresponding software, services or automation platforms, and avoid taking tools as the priority.
- Computational prediction results require experimental validation, and the value of the dry-wet closed loop lies in standardizing the validation process.
- The implementation of automated experimental platforms involves site and process transformation, and laboratory space and safety assessments should be conducted before launch.
- For cooperative projects, the ownership of data and intellectual property rights should be agreed in advance, especially the compound data generated jointly.
- Focus on the compliance qualifications and quality systems of each product and service, and the drug R&D link has high requirements for traceability.
- In addition, the positioning of the output of health AI is always "auxiliary understanding" rather than a diagnostic conclusion: it can help you translate report indicators and symptom descriptions into easier-to-understand language, but the use of drugs, surgery and treatment plans must be judged by licensed physicians.
- Please seek medical attention directly for emergency symptoms.
Traffic & popularity
Data month Sep 2026
XtalPi receives about 53.9K visits per month and ranks #387,140 worldwide.
Monthly visits
12 monthsTraffic sources
- Search60.6%
- Direct22.3%
- Referrals12.2%
- AI assistants4.6%
- Social0.2%
Top countries
- United States85.0%
- Taiwan, China6.4%
- Hong Kong, China4.4%
- Germany3.5%
- Japan0.5%
Estimated from third-party traffic data.
Similar tools
BioMapA life science large model enterprise, officially stating that it has independently developed the xTrimo basic model and the BioMap OS dry-wet closed-loop discovery system, supports data insights and de novo design, and provides discovery services such as antibodies and proteins to pharmaceutical companies and scientific research institutions.
Insilico MedicineInsilico Medicine is a clinical-stage biotech company using generative AI for drug discovery. Its platform includes PandaOmics for target identification, with public pipelines covering fibrosis and tumors. The drugs under research have not been marketed yet and should be taken under medical advice.
DeepTechAn AI for Science enterprise, officially stating that it takes DeepShine·Yuzhi Scientific Discovery Intelligent Engine as the foundation, builds tools such as Bohr Scientific Navigation and Lebesgue Intelligent Computing and scientific intelligent agents, targeting basic scientific research and drug and material R&D.
Docus AIDocus is an AI platform for medical testing institutions, providing test report interpretation, follow-up suggestions, compliance verification, and digital order forms, helping laboratories increase retest rates and operational efficiency.
SwanLabSwanLab is a model training and R&D tool launched by Emotion Machine. It provides training visualization, automatic log recording, hyperparameter recording, experiment comparison and multi-person collaboration capabilities, helping to improve R&D efficiency.
CuspAIA UK research company that uses AI to accelerate the discovery of new materials, registered in Cambridge, focuses on semiconductors, energy and climate. It partners with laboratories and industrial counterparts for collaboration through application.